INS and obesity disorder: Besides the increased pro-inflammatory markers, obesity is often associated with a decrease in adiponectin, an anti-inflammatory adipokine deemed beneficial against dyslipidemia and important in maintaining glucose and insulin homeostasis [34,177,178].